Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Haemophilus influenzae outer membrane proteins are a set of structurally and functionally diverse proteins localized to the outer membrane of the Gram-negative bacterium H. influenzae. They include major porins (e.g., P2) that permit nutrient uptake, adhesins (e.g., P5, PE, Hap) that mediate bacterial binding to host cells, and virulence factors that enable immune evasion by recruiting host regulators (such as factor H, C4b-binding protein, vitronectin) or reducing antibody binding[1][2][3][4][7]. Some, like P5, are essential for serum resistance and membrane integrity; others, like PE, are prominent in adherence and immune modulation[1][4]. These proteins are important contributors to respiratory tract colonization, pathogenesis, and persistence, and are being studied as vaccine targets. However, their sequence variability and redundancy present challenges for drug and vaccine development[1][4]. Key example members: - Protein P5: OmpA family, contributes to serum resistance, adherence, membrane stability, and possesses variable immunogenic extracellular loops[1][2]. - Protein P2: Major porin, forms channels for passive diffusion, impacts antibiotic sensitivity[7]. - Protein E (PE): Adhesin, binds laminin, vitronectin, plasminogen, and modulates local immune response[4]. - Autotransporters (Hap, Hia, Hsf): Mediate aggregation, biofilm formation, and additional adherence[3].
For antibiotics: disruption of outer membrane or inhibition of peptidoglycan; OMPs can mediate resistance/sensitivity[1][7]. For vaccines: induction of antibody responses against surface-exposed OMP loops or domains (block adherence or immune evasion)[4].
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Haemophilus influenzae outer membrane protein.